These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Neuroendocrine responses to single doses of buspirone in obsessive-compulsive disorder. Norman TR; Apostolopoulos M; Burrows GD; Judd FK Int Clin Psychopharmacol; 1994; 9(2):89-94. PubMed ID: 8056999 [TBL] [Abstract][Full Text] [Related]
28. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature]. Etain B; Bonnet-Perrin E Encephale; 2001; 27(3):280-9. PubMed ID: 11488259 [TBL] [Abstract][Full Text] [Related]
29. [Efficacy assessment of fluoxetine treatment of outpatients with obsessive-compulsive disorder: a preliminary report]. Wandzel L Psychiatr Pol; 1997; 31(4):429-35. PubMed ID: 9527686 [TBL] [Abstract][Full Text] [Related]
31. Serotonin syndrome from fluvoxamine and buspirone. Baetz M; Malcolm D Can J Psychiatry; 1995 Sep; 40(7):428-9. PubMed ID: 8548727 [No Abstract] [Full Text] [Related]
32. Fluoxetine treatment of obsessive-compulsive disorder: an open clinical trial. Liebowitz MR; Hollander E; Schneier F; Campeas R; Hatterer J; Papp L; Fairbanks J; Sandberg D; Davies S; Stein M J Clin Psychopharmacol; 1989 Dec; 9(6):423-7. PubMed ID: 2687337 [TBL] [Abstract][Full Text] [Related]
33. Obsessive-compulsive disorder in HIV disease. Response to fluoxetine. McDaniel JS; Johnson KM Psychosomatics; 1995; 36(2):147-50. PubMed ID: 7724717 [No Abstract] [Full Text] [Related]
34. Continuation treatment of OCD: double-blind and open-label experience with fluoxetine. Tollefson GD; Birkett M; Koran L; Genduso L J Clin Psychiatry; 1994 Oct; 55 Suppl():69-76; discussion 77-8. PubMed ID: 7961535 [TBL] [Abstract][Full Text] [Related]
35. Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder. Geller DA; Biederman J; Reed ED; Spencer T; Wilens TE J Am Acad Child Adolesc Psychiatry; 1995 Jan; 34(1):36-44. PubMed ID: 7860454 [TBL] [Abstract][Full Text] [Related]
36. [Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine]. Volk S Fortschr Neurol Psychiatr; 1995 Jun; 63 Suppl 1():28-32. PubMed ID: 7635392 [No Abstract] [Full Text] [Related]
37. Buspirone in obsessional compulsive disorder. A prospective case study. Farid BT; Bulto M Pharmacopsychiatry; 1994 Sep; 27(5):207-9. PubMed ID: 7838892 [TBL] [Abstract][Full Text] [Related]
38. Open trial of fluoxetine in obsessive-compulsive disorder. Jenike MA; Buttolph L; Baer L; Ricciardi J; Holland A Am J Psychiatry; 1989 Jul; 146(7):909-11. PubMed ID: 2787123 [TBL] [Abstract][Full Text] [Related]
39. Predictors of drug treatment response in obsessive-compulsive disorder. Ravizza L; Barzega G; Bellino S; Bogetto F; Maina G J Clin Psychiatry; 1995 Aug; 56(8):368-73. PubMed ID: 7635854 [TBL] [Abstract][Full Text] [Related]
40. Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder? Koran LM; Cain JW; Dominguez RA; Rush AJ; Thiemann S Am J Psychiatry; 1996 Nov; 153(11):1450-4. PubMed ID: 8890679 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]